Northern Light Eastern Maine Medical Center
Bangor, Maine 04401
6 studies enrolling now · 19 studies all time
What they study most
Acute Myocardial Infarction, Acute Myocardial Infarction (AMI), Arthroplasty, Replacement, Hip, Atherosclerotic Cardiovascular Disease, Bronchiolitis Acute, Cardiovascular Risk, Coronary Artery Disease, Coronary Heart Disease (CHD), Dilated Cardiomyopathy, Early Alzheimer's Disease, Early Alzheimer´s Disease, Heart Failure With Reduced Ejection Fraction (HFrEF)
Studies at this site
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine — Recruiting now
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
- I-DECIDE After Bronchiolitis Hospitalization — Recruiting now
- Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
- Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis — Available (expanded access)
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
- Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
- An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) — Completed
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- Tritanium® Primary Acetabular Shell Study — Stopped early
- PerQseal® Clinical Study — Running, not enrolling
- FAME II-10-year Follow-Up — Completed
- Percutaneous Localization: Open-label Registry of Thoracic Surgery — Completed